Showing 9 posts of 9 posts found.


Boehringer and Lupin team up to battle KRAS-driven cancers in $700m+ deal

September 5, 2019
Research and Development, Sales and Marketing Boehringer Ingelheim, Cancer, KRAS, Lupin, collaboration, pharma

Boehringer Ingelheim is set to join forces with Lupin after the pair sealed a partnership agreement to develop, license, and …


Lupin scoops up women’s health specialist Symbiomix for $150 million

October 11, 2017
Research and Development, Sales and Marketing India, Lupin, Lupin Pharmaceuticals, Symbiomix, US, acquisition, pharma

The US arm of Mumbai’s Lupin Pharmaceuticals has announced that it is has acquired US-based gynaecologic treatment specialist Symbiomix Therapeutics …

Lupin drops on FDA observations; company reassures of no disruption at facility

March 29, 2016
Business Services, Manufacturing and Production, Sales and Marketing Lupin, US FDA, regulation

Shares of India’s Lupin dropped over 14% Tuesday following news the US Food and Drug Administration (FDA) has made observations …


Lupin completes acquisition of US-based Gavis Pharmaceuticals

March 10, 2016
Research and Development, Sales and Marketing FDA, Gavis, Lupin, acquisition, generics

Indian drug manufacturer Lupin has announced the completion of its acquisition of New Jersey-based pharmaceutical firm, Gavis, in a deal …


Lupin to set up manufacturing plant in Japan

March 1, 2016
Manufacturing and Production Japan, Lupin, manufacturing

Indian drugmaker Lupin is, via its Japanese unit Kyowa, setting up a manufacturing unit in Japan as part of its …

India flag

Lupin buys Gavis to gain first US manufacturing site

July 28, 2015
Manufacturing and Production Gavis, Lupin, manufacturing, production

Indian drug manufacturer Lupin is expanding to the US by purchasing Gavis pharma for $880 million, in a major boost …

servier image

Servier fined €331m by European Commission

July 10, 2014
Sales and Marketing EC, European Commission, France, Krka, Lupin, Matrix, Mylan, Niche/Unichem, Servier, Teva

The European Commission has served French pharma company Servier with a €331 million fine for delaying the entry to market …


Lupin adds chief corporate development officer

April 25, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Lupin, theresa stevens

Mumbai-based pharma firm Lupin has hired Theresa Stevens to be its chief corporate development officer.   Stevens will be assuming …

Manufacturing news in brief

January 25, 2010
Manufacturing and Production Elona Biotech, Genzyme, Lupin, Patheon, State Pharmaceuticals Manufacturing, SurModics

Our round-up of developments in pharmaceutical manufacturing includes a new contract between Patheon and Sanofi-Aventis, hiring plans at Genzyme and …

Latest content